Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?

Although SARS-CoV-2 is considered a lung-tropic virus, severe COVID-19 is not just a viral pulmonary infection, clinically it is a multi-organ pathology with major coagulation abnormalities and thromboembolism events. Recently, antiphospholipid (aPL) antibodies were found increased in a large number...

Descripción completa

Detalles Bibliográficos
Autores principales: Devaux, Christian A., Camoin-Jau, Laurence, Mege, Jean-Louis, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783458/
https://www.ncbi.nlm.nih.gov/pubmed/33500211
http://dx.doi.org/10.1016/j.jmii.2020.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783458/
https://www.ncbi.nlm.nih.gov/pubmed/33500211
http://dx.doi.org/10.1016/j.jmii.2020.12.010

Ejemplares similares